Jan Pype
Inventor
Stats
- 0 US patents issued
- 11 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 11 US Applications Filed
- 5 Total Citation Count
- Feb 5, 2024 Most Recent Filing
- Jan 21, 2011 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE | 2
1 3 | 2011
2012 2014 |
L'INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE | 1
| 2014
|
Inventor Addresses
Address | Duration |
---|---|
Herne, BE | Nov 29, 12 - Oct 17, 24 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 10 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 6 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2024/0343,823 | 2024 | POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING GLYPICAN-3 AND T CELL RECEPTOR | 0 |
11932702 | 2024 | Polypeptides comprising immunoglobulin single variable domains targeting glypican-3 and T cell receptor | 0 |
11919966 | 2024 | Methods for inhibiting tumor growth or treating cancer by administering an immunoglobulin single variable domain that binds glucocorticoid-induced TNFR family-related receptor (GITR) | 0 |
2022/0411,521 | 2022 | POLYPEPTIDES THAT BIND GLUCOCORTICOID-INDUCED TNFR FAMILY-RELATED RECEPTOR (GITR) | 0 |
2022/0213,215 | 2022 | POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING GLYPICAN-3 AND T CELL RECEPTOR | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.